MPO and cancer: The expression of the enzyme myeloperoxidase (MPO) was selected as an inflammatory marker due to evidence supporting MPO as a reliable inflammatory marker in a range of pathogenesis including cancer, rheumatoid arthritis and cardiovascular disease in addition to tissue injury [73].